Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

SBFM

Sunshine Biopharma (SBFM)

Sunshine Biopharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SBFM
FechaHoraFuenteTítuloSímboloCompañía
06/03/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
05/03/202415:37Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SBFMSunshine Biopharma Inc
05/03/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
23/02/202415:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
14/02/202410:18Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SBFMSunshine Biopharma Inc
12/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SBFMSunshine Biopharma Inc
09/02/202416:17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SBFMSunshine Biopharma Inc
09/02/202407:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
01/02/202415:17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SBFMSunshine Biopharma Inc
08/01/202407:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SBFMSunshine Biopharma Inc
04/12/202307:30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMSunshine Biopharma Inc
13/11/202307:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMSunshine Biopharma Inc
19/10/202311:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SBFMSunshine Biopharma Inc
18/10/202312:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
25/08/202314:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
11/08/202307:30GlobeNewswire Inc.Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%NASDAQ:SBFMSunshine Biopharma Inc
06/06/202305:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBFMSunshine Biopharma Inc
05/06/202316:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SBFMSunshine Biopharma Inc
25/05/202315:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SBFMSunshine Biopharma Inc
17/05/202312:31Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SBFMSunshine Biopharma Inc
16/05/202308:58GlobeNewswire Inc.Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMSunshine Biopharma Inc
12/05/202307:00GlobeNewswire Inc.Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMSunshine Biopharma Inc
11/05/202316:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBFMSunshine Biopharma Inc
11/05/202308:00GlobeNewswire Inc.Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%NASDAQ:SBFMSunshine Biopharma Inc
10/05/202315:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SBFMSunshine Biopharma Inc
05/04/202307:00GlobeNewswire Inc.Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate UpdateNASDAQ:SBFMSunshine Biopharma Inc
04/04/202305:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SBFMSunshine Biopharma Inc
28/02/202306:30GlobeNewswire Inc.Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 TreatmentNASDAQ:SBFMSunshine Biopharma Inc
10/02/202306:35GlobeNewswire Inc.Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer CompoundNASDAQ:SBFMSunshine Biopharma Inc
19/01/202306:30GlobeNewswire Inc.Sunshine Biopharma Announces Share Repurchase ProgramNASDAQ:SBFMSunshine Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:SBFM